Grants per year
Personal profile
Education/Academic qualification
Medicine, MD, Washington University
… → 1995
Fingerprint
Dive into the research topics where Amy B Heimberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting macrophage reprogramming in glioblastoma
Chen, P., Heimberger, A. B. & Zhang, H.
National Institute of Neurological Disorders and Stroke
9/1/23 → 8/31/28
Project: Research project
-
Project 2
Avery, R. J., Balyasnikova, I. V., Heimberger, A. B., Lukas, R. V., Procissi, D. & Sonabend Worthalter, A. M.
8/1/23 → 7/31/28
Project: Research project
-
SPORE for Translational Approaches to Brain Cancer
Lesniak, M. S., Heimberger, A. B. & James, C. D.
8/1/23 → 7/31/28
Project: Research project
-
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
Heimberger, A. B., Kumthekar, P. U., Hill, V. B., Kocherginsky, M. & Sachdev, S.
5/5/23 → 4/30/28
Project: Research project
-
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
12/1/22 → 11/30/25
Project: Research project
-
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin
Liang, J., Fang, D., Gumin, J., Najem, H., Sooreshjani, M., Song, R., Sabbagh, A., Kong, L. Y., Duffy, J., Balyasnikova, I. V., Pollack, S. M., Puduvalli, V. K. & Heimberger, A. B., Feb 2023, In: Cancers. 15, 4, 1085.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Aspirin and immunotherapy: A Faustian bargain?
Goethe, E. A., Heimberger, A. B. & Rao, G., May 1 2023, In: Journal of Clinical Investigation. 133, 9, e169598.Research output: Contribution to journal › Review article › peer-review
Open Access -
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Dmello, C., Zhao, J., Chen, L., Gould, A., Castro, B., Arrieta, V. A., Zhang, D. Y., Kim, K. S., Kanojia, D., Zhang, P., Miska, J., Yeeravalli, R., Habashy, K., Saganty, R., Kang, S. J., Fares, J., Liu, C., Dunn, G., Bartom, E., Schipma, M. J., & 7 others, Dec 2023, In: Nature communications. 14, 1, 1566.Research output: Contribution to journal › Article › peer-review
Open Access -
Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma
Pang, L., Dunterman, M., Xuan, W., Gonzalez, A., Lin, Y., Hsu, W. H., Khan, F., Hagan, R. S., Muller, W. A., Heimberger, A. B. & Chen, P., Feb 28 2023, In: Cell reports. 42, 2, 112127.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma
Khan, A. B., Lee, S., Harmanci, A. S., Patel, R., Latha, K., Yang, Y., Marisetty, A., Lee, H. K., Heimberger, A. B., Fuller, G. N., Deneen, B. & Rao, G., Feb 15 2023, In: International Journal of Cancer. 152, 4, p. 713-724 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Datasets
-
Additional file 1 of Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
Dardis, C. (Creator), Donner, D. (Creator), Sanai, N. (Creator), Xiu, J. (Creator), Mittal, S. (Creator), Michelhaugh, S. K. (Creator), Pandey, M. (Creator), Kesari, S. (Creator), Heimberger, A. B. (Creator), Gatalica, Z. (Creator), Korn, M. W. (Creator), Sumrall, A. L. (Creator) & Phuphanich, S. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.14833188, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Gliosarcoma_vs_glioblastoma_a_retrospective_case_series_using_molecular_profiling/14833188
Dataset
-
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
Dardis, C. (Creator), Donner, D. (Creator), Sanai, N. (Creator), Xiu, J. (Creator), Mittal, S. (Creator), Michelhaugh, S. K. (Creator), Pandey, M. (Creator), Kesari, S. (Creator), Heimberger, A. B. (Creator), Gatalica, Z. (Creator), Korn, M. W. (Creator), Sumrall, A. L. (Creator) & Phuphanich, S. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.c.5480628, https://springernature.figshare.com/collections/Gliosarcoma_vs_glioblastoma_a_retrospective_case_series_using_molecular_profiling/5480628
Dataset
-
Supplementary Tables 1 and 2. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
Groot, J. D. (Contributor), Ott, M. (Creator), Wei, J. (Creator), Kassab, C. (Creator), Fang, D. (Creator), Najem, H. (Creator), O'Brien, B. (Contributor), Weathers, S. (Creator), Majd, N. K. (Creator), Harrison, R. A. (Creator), Fuller, G. N. (Contributor), Huse, J. T. (Creator), Long, J. P. (Creator), Sawaya, R. (Creator), Rao, G. (Creator), Macdonald, T. J. (Contributor), Priebe, W. (Creator), DeCuypere, M. G. (Contributor), Heimberger, A. B. (Creator), MacDonald, T. J. (Creator) & Heimberger, A. B. (Creator), Future Science Group, 2022
DOI: 10.25402/fsg.19771747.v1, https://future-science-group.figshare.com/articles/dataset/Supplementary_Tables_1_and_2_A_first-in-human_Phase_I_trial_of_the_oral_p-STAT3_inhibitor_WP1066_in_patients_with_recurrent_malignant_glioma_/19771747/1
Dataset